CBL Patras S.A.
Petros Papadatos is an experienced Information Technology professional with a diverse background in IT supervision, system administration, and technical support. Currently serving as Information Technology Supervisor at CBL Patras S.A. since October 2020, Papadatos executes director duties and has previously held roles including Administrator of Computerized Systems and Network, as well as Junior IT Administrator and Help Desk Specialist at Hellenic-cam and Corfu Resorts. Prior experience includes IT support for the Hellenic Army, with responsibilities such as compliance with ISO 27001:2013, network administration, and troubleshooting. Papadatos possesses a Bachelor's degree in Electrical Engineering and Computer Engineering from the University of Peloponnese, completed in June 2021.
This person is not in the org chart
This person is not in any teams
CBL Patras S.A.
A high-technology peptide manufacturer, CBL (Chemical and Biopharmaceutical Laboratories of Patras S.A.) was founded by Prof. Kleomenis Barlos in 1990. It is located in the Industrial Area of Patras and has been linked with innovation and high technology in the field of pharmaceutical products on a global level for the past twenty years. CBL company deals in research for the manufacture of new products, the improvement of production methods of chemical, bio-chemical, pharmaceutical and natural products, as well as the trading of model substances which have been the result of the research activity and technological expertise of CBL. The company is acknowledged as one of the leading suppliers in the field. Its range of products include: • peptide starting materials • peptide intermediates • industrial and commercial-scale manufacturing of proprietary and generic GMP and non-GMP peptides CBL is a leader in the production industry of pharmaceutical raw materials. The company invests in innovation in order to pioneer its field. Significant co-operations have been built to achieve transition from laboratory to industrial scale with considerable success. All production phases are fully automated and facilities are entirely GMP compliant. Production is achieved via chemical reactions carried out in specially designed and fully equipped reactors. Reactions are conducted within solvents chanelled inside closed systems. Solvents are retrived upon completion of the prosess. The products of the reactions are isolated by means of crystallisation, filtration, extraction etc carried out within state-of-the-art technology closed systems. The products are dried or clarified depending on their natural form and are packed in containers as liquids or powder.